Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents

被引:44
作者
Ertan, Tugba
Yildiz, Ilkay [1 ]
Ozkan, Semiha
Temiz-Arpaci, Ozlem
Kaynak, Fatma
Yalcin, Ismail
Aki-Sener, Esin
Abbasoglu, Ufuk
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-06100 Ankara, Turkey
[2] Gazi Univ, Fac Pharm, Dept Pharmaceut Microbiol, TR-06330 Ankara, Turkey
关键词
antibacterial activity; antifungal activity; benzamide; phenylacetamide;
D O I
10.1016/j.bmc.2006.12.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new series of N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamide and phenylacetamide derivatives (la-In, 2a-2n) were synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, and their drug-resistant isolates. Microbiological results indicated that the compounds possessed a broad spectrum of activity against the tested microorganisms at MIC values between 500 and 1.95 mu g/ml. Benzamide derivative Id exhibited the greatest activity with MIC values of 1.95, 3.9, and 7.8 mu g/ml against drug-resistant B. subtilis, B. subtilis, and S. aureus, respectively. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2032 / 2044
页数:13
相关论文
共 22 条
[1]   Novel antibacterial agents for the treatment of serious Gram-positive infections [J].
Abbanat, D ;
Macielag, M ;
Bush, K .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) :379-399
[2]   Synthesis and microbiological activity of some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the possible metabolites of antimicrobial active benzoxazoles [J].
Aki-Sener, E ;
Bingöl, KK ;
Temiz-Arpaci, Ö ;
Yalçin, I ;
Altanlar, N .
FARMACO, 2002, 57 (06) :451-456
[3]  
AKISENER E, 2000, FARMACO, V55, P469
[4]  
Arakawa K, 1997, CHEM PHARM BULL, V45, P1984
[5]  
*CLSI NCCLS, 2006, A2A9 CLSI NCCLS
[6]  
*CLSI NCCLS, 2006, M27A CLSI NCCLS
[7]  
*CLSI NCCLS, 2006, M100S16 CLSI NCCLS
[8]   QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA AND STAPHYLOCOCCUS-AUREUS - DEVELOPMENT DURING THERAPY AND CLINICAL-SIGNIFICANCE [J].
DALHOFF, A .
INFECTION, 1994, 22 :S111-S121
[9]  
Itaru S., 1973, Japan Patent, Patent No. [73,37,819, 7337819]
[10]   In vitro anti-Helicobacter pylori activity of BAS-118, a new benzamide derivative [J].
Kobayashi, I ;
Muraoka, H ;
Hasegawa, M ;
Saika, T ;
Nishida, M ;
Kawamura, M ;
Ando, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) :129-132